Oncotarget: Targeted Ovarian Cancer Treatment

(50)

Oncotarget: Targeting mesothelin with high cytotoxic activity

(6:52)

HER3: A Vital Target in Cancer Treatment | Oncotarget

(8:49)

Targeting Lipid Metabolism in the Treatment of Ovarian Cancer | Oncotarget

(8:23)

Oncotarget: T-Cell-Targeted Immunotherapy for Recurrent HNSCC

(57)

Oncotarget: LAT1 - A Promising Anti-Cancer Target

(43)

Next-Gen Cell-Penetrating Antibodies for Tumor Targeting and RAD51 Inhibition | Oncotarget

(1:30)

Oncotarget: Researchers identify potential therapeutic target in aggressive breast cancer cells

(7:24)

Increase Your Mitochondria, Your Body Will Thank You | The Acid Drop

(11:7)

Grow and Propagate Your Own Jiaogulan - Gynostemma Pentaphyllum

(2:57)

Intro to Proteomics / Mass Spectrometry (MS)

(21:7)

Oncotarget: Osteoprotegerin rich tumor microenvironment: implications in breast cancer

(4:54)

Viewpoint Molecular Targeting: Targeted Cancer Therapies

(6:8)

Topoisomerase Inhibitors Part 2

(9:34)

Clevers H (2015): Wnt signaling, Lgr5 stem cells, organoids and cancer

(37:43)

أعراض ورم المخ

(3:19)

علاج الاورام من المرحله الرابعه

(4:35)

Oncotarget | Exploratory Study of Metformin and Rapamycin as Maintenance Therapy

(6:21)

Oncotarget: Camptothecin targets WRN protein: in clinical breast cancer

(7:39)

Targeting WNT5B and WNT10B in Osteosarcoma | Oncotarget

(1:5)

Repurposing DPP4 Inhibitors for Target Therapy Resistance in Renal Cell Carcinoma | Oncotarget

(1:17)

The Nuclear Envelope and Metastasis | Oncotarget

(1:4)

Oncotarget: A procaspase-3 activator and temozolomide extends survival in glioma models

(6:44)

Updates on MET Targeted Therapy for EXON 14 Mutations in Lung Cancer | Oncotarget

(1:17)

Oncotarget: ONC201 kills breast cancer cells in vitro by targeting mitochondria

(12:54)

FOXM1 and PD-L1 in CDK4/6-MEK Resistance in Nerve Tumors | Oncotarget

(1:44)

Proof-of-Principle: Targeted Childhood Leukemia Prevention | Oncotarget

(1:25)

Targeting Ras with Protein Engineering | Oncotarget

(2:14)

Immunotherapy Success in KRAS G12C Adenosquamous Pancreatic Cancer | Oncotarget

(1:45)